[Treatment of cutaneous leishmaniasis with glucantime. Apropos of 9 cases].
D000328:Adult; D000965:Antimony / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003462:Cuba; D004197:Disease Reservoirs; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D008536:Meglumine; D000077485:Meglumine Antimoniate; D009527:Nicaragua / Q000208:ethnology; D009942:Organometallic Compounds
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony
Tratamiento de la leishmaniasis cutánea con glucantime. A propósito de nueve casos.